Financing news: The veteran of two biotech companies — Napo Pharmaceuticals Inc. and Shaman Pharmaceuticals Inc. — is leading a new company toward a planned $70 million initial public offering .
San Francisco’s Jaguar Animal Health Inc., which would trade on the NASDAQ exchange as “JAGX,” is focused on gastrointestinal drugs for animals.
Jaguar had cash and equivalents of $4.3 million as of June 30. It lost $4.2 million in the first six months of this year.
For further deal information visit Current Agreements (subscription required)
Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary
Report: Finding Biopharma and Collaboration Partners
Related reports: Entire Current Partnering reports catalog
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering Insight Financing Scorecard – view top life science financing deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity